High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone-Reference-Cited by-同舟云学术

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone

Published:2011-10-31 Issue:5 Volume:53 Page:849-854
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Suzuki Kazuhito,Terui Yasuhito,Nakano Kenji,Nara Eriko,Nasu Kentaro,Ueda Kyoko,Nishimura Noriko,Mishima Yuko,Sakajiri Sakura,Yokoyama Masahiro,Takahashi Shunji,Hatake Kiyohiko

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.635858

Reference41 articles.

1. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

2. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

3. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients;Anticancer Research;2021-01-30

2. There is life in the old dog yet: thymidine kinase as predictive marker in diffuse large B-cell lymphoma;Leukemia & Lymphoma;2013-07-16

3. Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone;Leukemia & Lymphoma;2013-03-14